Elena Battaiotto
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Anti-EGFR rechallenge compared with standard of care for patients with ctDNA RAS/BRAF wild-type chemorefractory metastatic colorectal cancer: A systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: November 27, 2025
Metastasis-directed thermal ablation in patients with metastatic breast cancer and visceral oligoprogression or oligopersistence: a cohort study.
Journal: Breast (Edinburgh, Scotland)
Published: September 14, 2025
Management of MET-Driven Resistance to Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer.
Journal: Genes
Published: June 03, 2025
HER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs-A Long Way to the Top.
Journal: Molecules (Basel, Switzerland)
Published: May 06, 2025
An update on promising and emerging protein kinase B/AKT inhibitors for breast cancer.
Journal: Expert opinion on pharmacotherapy
Published: January 23, 2025
Metastasis-directed stereotactic radiotherapy and systemic treatment continuation for patients with oligoprogressive metastatic breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 11, 2024
The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis.
Journal: The oncologist
Published: September 09, 2024
Molecular tumor board in patients with metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: August 27, 2024
Metronomic Chemotherapy in Breast Cancer as a Strategy to Deliver More Sustainable and Less Toxic Treatments: Time to Debunk the Myth?
Journal: Clinical breast cancer
Published: August 05, 2024
Last Updated: 09/26/2026